Literature DB >> 8151470

Immune responses to the Escherichia coli dnaJ heat shock protein in juvenile rheumatoid arthritis and their correlation with disease activity.

S Albani1, A Ravelli, M Massa, F De Benedetti, G Andree, J Roudier, A Martini, D A Carson.   

Abstract

Patients with juvenile rheumatoid arthritis frequently have abnormal immune responses to the hsp65 class of bacterial heat shock proteins. However, lymphocytes from children with other inflammatory diseases may also recognize hsp65, and the role of these antigens in juvenile rheumatoid arthritis remains controversial. We have studied humoral and cellular immune responses to a distinct, recently described bacterial heat shock protein, designated dnaJ. The Escherichia coli dnaJ gene was cloned and expressed, and the purified recombinant protein was used as an antigen. Neither normal children nor children with various chronic inflammatory diseases had lymphocyte proliferative responses to recombinant dnaJ. However, lymphocytes from patients with polyarticular, pauciarticular, and systemic manifestations of juvenile rheumatoid arthritis responded strongly to the antigen. Cellular immune responses to dnaJ were higher in synovial fluid than in blood and higher in children with active disease than in children in remission. These data show that increased immune reactivity to dnaJ is characteristic of juvenile rheumatoid arthritis and that the magnitude of the immune response is linked to disease activity. The results suggest that an abnormal immune response to antigens on commensal gut bacteria may contribute to the generation of chronic inflammation in juvenile rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8151470     DOI: 10.1016/s0022-3476(05)83134-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  12 in total

Review 1.  The role of immune tolerance in preventing and treating arthritis.

Authors:  Gijs Teklenburg; Salvatore Albani
Journal:  Curr Rheumatol Rep       Date:  2004-12       Impact factor: 4.592

Review 2.  Immunopathogenesis of juvenile rheumatoid arthritis: role of T cells and MHC.

Authors:  L I Sakkas; C D Platsoucas
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

3.  Decreased T cell precursor frequencies to Epstein-Barr virus glycoprotein Gp110 in peripheral blood correlate with disease activity and severity in patients with rheumatoid arthritis.

Authors:  E Toussirot; D Wendling; P Tiberghien; J Luka; J Roudier
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

Review 4.  The Epstein-Barr virus in autoimmunity.

Authors:  J H Vaughan
Journal:  Springer Semin Immunopathol       Date:  1995

Review 5.  Heat shock proteins in juvenile idiopathic arthritis: keys for understanding remitting arthritis and candidate antigens for immune therapy.

Authors:  Berent Prakken; Wietse Kuis; Willem van Eden; Salvatore Albani
Journal:  Curr Rheumatol Rep       Date:  2002-12       Impact factor: 4.592

6.  Hsp40 proteins modulate humoral and cellular immune response in rheumatoid arthritis patients.

Authors:  Stefan Tukaj; Agnieszka Kotlarz; Agnieszka Jozwik; Zaneta Smolenska; Ewa Bryl; Jacek M Witkowski; Barbara Lipinska
Journal:  Cell Stress Chaperones       Date:  2010-02-02       Impact factor: 3.667

Review 7.  Heat shock protein bystander antigens for peptide immunotherapy in autoimmune disease.

Authors:  E Zonneveld-Huijssoon; S Albani; B J Prakken; F van Wijk
Journal:  Clin Exp Immunol       Date:  2013-01       Impact factor: 4.330

8.  Novel self-epitopes derived from aggrecan, fibrillin, and matrix metalloproteinase-3 drive distinct autoreactive T-cell responses in juvenile idiopathic arthritis and in health.

Authors:  Sylvia Kamphuis; Kolbrún Hrafnkelsdóttir; Mark R Klein; Wilco de Jager; Margje H Haverkamp; Jolanda H M van Bilsen; Salvatore Albani; Wietse Kuis; Marca H M Wauben; Berent J Prakken
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

9.  Modulation of T cell function by combination of epitope specific and low dose anticytokine therapy controls autoimmune arthritis.

Authors:  Sarah T A Roord; Evelien Zonneveld-Huijssoon; Tho Le; Gisella Puga Yung; Eva Koffeman; Arash Ronaghy; Negar Ghahramani; Paola Lanza; Rosario Billetta; Berent J Prakken; Salvatore Albani
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

Review 10.  Heat shock protein 60 reactive T cells in juvenile idiopathic arthritis: what is new?

Authors:  Yvonne Vercoulen; Nienke H van Teijlingen; Ismé M de Kleer; Sylvia Kamphuis; Salvatore Albani; Berent J Prakken
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.